Wernly, Bernhard <br/><br/>
Triple therapy: worth the risk?  [electronic resource] 

 -  Minerva medica  Oct 2018 
 - 403-405 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis 
<br/><br/><label>ISSN: </label>1827-1669 
<br/><br/><label>Standard No.: </label>10.23736/S0026-4806.18.05564-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anticoagulants--administration & dosage<br/>Aspirin--administration & dosage<br/>Clopidogrel<br/>Drug Synergism<br/>Drug Therapy, Combination--adverse effects<br/>Factor Xa Inhibitors--administration & dosage<br/>Hemorrhage--chemically induced<br/>Humans<br/>Mortality<br/>Multicenter Studies as Topic<br/>Myocardial Infarction--etiology<br/>Platelet Aggregation Inhibitors--administration & dosage<br/>Postoperative Complications--prevention & control<br/>Purinergic P2Y Receptor Antagonists--administration & dosage<br/>Randomized Controlled Trials as Topic<br/>Rivaroxaban--administration & dosage<br/>Stents<br/>Stroke--prevention & control<br/>Thrombophilia--drug therapy<br/>Ticlopidine--administration & dosage